HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Serotonin syndrome associated with polypharmacy in the elderly.

Abstract
The increasing use of serotonergic agents, alone and in combination, across multiple disciplines, makes it likely that the prevalence of serotonin syndrome will rise. Caution should be used, especially in the elderly, to avoid unnecessary and potentially harmful polypharmacy. We describe a case of serotonin syndrome in a 79-year-old man taking mirtazapine, venlafaxine and quetiapine. As this case illustrates, serotonin syndrome can be caused by combinations of direct serotonin agonists (e.g., serotonergic antidepressants) and indirect serotonin agonists (e.g., atypical antipsychotics).
AuthorsBrian D Poeschla, Pauline Bartle, Karen P Hansen
JournalGeneral hospital psychiatry (Gen Hosp Psychiatry) 2011 May-Jun Vol. 33 Issue 3 Pg. 301.e9-11 ISSN: 1873-7714 [Electronic] United States
PMID21601732 (Publication Type: Case Reports, Journal Article)
CopyrightCopyright © 2011 Elsevier Inc. All rights reserved.
Chemical References
  • Serotonin Agents
Topics
  • Aged
  • Humans
  • Male
  • Polypharmacy
  • Serotonin Agents (administration & dosage, adverse effects, therapeutic use)
  • Serotonin Syndrome (chemically induced)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: